Effects of morbidity, age, gender and region on percutaneous transluminal coronary angioplasty (PTCA) utilisation

R Strauss1, C Pfeifer, V Muhlberger

  • 1Ludwig-Boltzmann-Institute for Epidemiology and Research on Health Systems, University of Innsbruck, Austria.

Public Health
|June 4, 1999
PubMed

Insights

Percutaneous Transluminal Coronary Angioplasty (PTCA) use increased from 1993-1995, but women and older individuals received fewer interventions. Geographical disparities in PTCA application were noted, unrelated to patient morbidity.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Coronary heart disease, including myocardial infarction and angina pectoris, affects a significant portion of the population.
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) is a key intervention for managing coronary artery disease.
  • Understanding trends in PTCA utilization is crucial for equitable healthcare delivery.

Purpose of the Study:

  • To analyze changes in PTCA application rates concerning patient demographics (age, gender) and geographical variations.
  • To examine the relationship between patient morbidity and the geographical distribution of PTCA procedures.
  • To identify disparities in PTCA utilization across different population subgroups and regions in Austria.

Main Methods:

  • A retrospective record linkage study was conducted.
  • Data from all 156 Austrian hospitals and cardiology centers performing the Minimum Basic Data Set (MBDS) were analyzed.
  • The study included all Austrian residents diagnosed with myocardial infarction, coronary heart disease, or angina pectoris between 1993 and 1995.

Main Results:

  • The PTCA intervention rate increased from 33% in 1993 to 40% in 1995.
  • Significant gender disparities were observed, with men receiving PTCA more frequently than women (OR=2.8).
  • Marked geographical differences in PTCA rates were found, but these did not correlate with morbidity rates.

Conclusions:

  • PTCA utilization varied significantly by age, gender, and region, with women and older populations receiving fewer interventions.
  • The study highlights a need for further investigation into supply-side, economic, and social factors influencing PTCA access.
  • Public health strategies are recommended to ensure equitable PTCA utilization across the Austrian population.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...